News
New Phesi global analysis shows breast cancer was the most extensively studied disease area in 2021
Phesi Inc., a data-driven provider of AI-powered clinical development analytics and solutions, has released the results of its global analysis of all clinical trials...
White Papers
Bridging the Gap: Manufacturing Software and the Paperless Imperative
You know you need to go paperless on your manufacturing floor, to reduce human error, increase time to market and get quality off your...
News
AES Clean Technology Accelerates Cleanroom Capabilities with $14.2 million Investment
AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and bio-pharmaceutical industry, announced a $14.2 million investment to open a...
News
Cabenuva HIV Drug From GlaxoSmithKline Gets FDA Approval
Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was regarded as a peerless...
News
In GSK Patent Settlement, Gilead To Pay $1.25B On Biktarvy
It doesn’t come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are fighting out in HIV domain for a long time,...
Packaging & Labelling
Sensitech Launches App-Enabled, Touchless Temperature Monitoring Solution for Enhanced Supply Chain Visibility
Sensitech, a leading provider of global supply chain visibility solutions, launched the TempTale® Ultra BLE, the newest wireless addition to its industry-leading line of...
Drug Research
Biogen Exercises Option to Participate in the Development and Commercialization of a Late-Stage Bispecific Antibody
Biogen Inc. announced that it exercised its option to participate in the development and commercialization of mosunetuzumab. Biogen will pay a $30 million one-time...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read